Kura Oncology, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
KURA on Nasdaq
Industry
Pharmaceutical Preparations
Location
12730 High Bluff Drive, Suite 400, San Diego, CA

Insiders trading volume in the past year

Kura Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Troy E. Wilson President and CEO, Director $5.69M +$386K +7.27% Nov 13, 2025
Mollie Leoni Chief Medical Officer $2.52M -$322K -11.3% Nov 13, 2025
Teresa Bair Chief Legal Officer $2.1M -$244K -10.4% Nov 13, 2025
Brian Powl Chief Commercial Officer $1.56M -$191K -10.9% Nov 13, 2025
Thomas Doyle SVP, Finance & Accounting $1.46M -$130K -8.2% Nov 13, 2025
Kathleen Ford Chief Operating Officer $1.18M -$163K -12.1% Nov 13, 2025
Stephen Dale Chief Medical Officer $837K Jan 29, 2024
Marc Grasso Cfo, Cbo $252K Jan 26, 2022
Kirsten Flowers CCO & Chief Strategy Officer $237K Jan 27, 2023
Faheem Hasnain Director $192K -$181K -48.6% Jun 5, 2025
Francis Burrows Chief Scientific Officer $163K -$17.1K -9.47% Jan 28, 2025
Carol Schafer Director Jun 5, 2025
Robert E. Hoffman Director Jun 22, 2021
Thomas Malley Director Jun 5, 2025
Mary T. Szela Director Jun 5, 2025
Michael Vasconcelles Director Jun 5, 2025
Steven H. Stein Director Jun 21, 2022
Helen Louise Collins Director Jun 5, 2025
Diane L. Parks Director Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for Kura Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.